Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the main cause of dementia, with an estimated prevalence of 50 million people worldwide that is projected to triple by 2050. Masitinib is an orally administered
Maximize the informational quality of your email inbox by selectively subscribing to evidence-based health and wellness resources that are informed by rigorous scientific research and medical expertise.
Your privacy is important to us
© 2020-2022 HealthSciaxis a Sciaxis Company. All rights reserved. Our website services, content, and products are for informational purposes only. HealthSciaxis does not provide medical advice, diagnosis, or treatment. See additional information.
